Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LINAGLIPTIN vs LINCOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LINAGLIPTIN vs LINCOMYCIN: Safety Overview

Metric LINAGLIPTIN LINCOMYCIN
Total FAERS Reports 7,762 210
Deaths Reported 726 21
Death Rate 9.4% 10.0%
Hospitalizations 2,794 37
Average Patient Age 70.2 yrs 46.3 yrs
% Female Patients 51.8% 69.3%
FDA Approval Date Aug 31, 2021 Approved Prior to Jan 1, 1982
Manufacturer Novadoz Pharmaceuticals LLC Pharmacia & Upjohn Company LLC
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Discontinued